Sign in
4

Changes in Ownership

Structure Therapeutics Inc. Filed Acc 0001963664-26-000003

CHIEF TECHNOLOGY OFFICER acquired 32,526 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Ma Yingli CHIEF TECHNOLOGY OFFICER 2026-03-19 Grant or award +32,526 139,917 D
Derivatives
Ma Yingli CHIEF TECHNOLOGY OFFICER 2026-03-19 Grant or award · Employee Stock Option (right to buy) +40,278 40,278 D
Loading xslF345X06/form4-03232026_040307.xml…